Aclaris Therapeutics
ACRS
#7753
Rank
NZ$0.60 B
Marketcap
NZ$5.54
Share price
-2.28%
Change (1 day)
-17.20%
Change (1 year)

Earnings for Aclaris Therapeutics (ACRS)

Earnings in 2025 (TTM): -NZ$0.25 Billion

According to Aclaris Therapeutics's latest financial reports the company's current earnings are NZ$15.74 Million. In 2024 the company made an earning of -NZ$0.23 Billion a decrease over its 2023 earnings that were of -NZ$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aclaris Therapeutics from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.25 Billion8.7%
2024 -NZ$0.23 Billion48.64%
2023 -NZ$0.16 Billion2.23%
2022 -NZ$0.16 Billion-4.35%
2021 -NZ$0.16 Billion77%
2020 -NZ$88.82 Million-54.79%
2019 -NZ$0.2 Billion-5.87%
2018 -NZ$0.21 Billion71.46%
2017 -NZ$0.13 Billion46.33%
2016 -NZ$83.18 Million133.81%
2015 -NZ$35.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-NZ$0.26 Billion 4.48%๐Ÿ‡บ๐Ÿ‡ธ USA